Mindfulness-Based Yoga in Schizophrenia (MBY-SCZ)

March 23, 2026 updated by: Aysel AKBENIZ, Tarsus University

The Effect of Mindfulness-Based Yoga on Psychological Well-Being and Happiness in Individuals With Schizophrenia: A Randomized Controlled Trial

This randomized controlled trial aimed to evaluate the effect of mindfulness-based yoga on psychological well-being and happiness in individuals diagnosed with schizophrenia. Participants were recruited from community mental health centers and randomly assigned to either an intervention group or a control group.

The intervention group participated in a structured mindfulness-based yoga program consisting of 12 sessions over six weeks, including mindfulness practices, breathing exercises, meditation, and yoga postures. The control group received routine care without additional intervention.

Primary outcomes included psychological well-being and happiness, measured using validated scales at baseline and post-intervention. The findings of the study are expected to contribute to the development of psychosocial interventions that support mental health and well-being in individuals with schizophrenia.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

91

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Tarsus
      • Mersin, Tarsus, Turkey (Türkiye), 33400
        • Tarsus University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with schizophrenia according to DSM-5 criteria

  • Aged between 18 and 65 years

    • Willing to participate in the study
    • Able to provide informed consent

Exclusion Criteria:

  • Being in an acute exacerbation phase of schizophrenia
  • Participation in mindfulness or yoga training within the last 6 months
  • Presence of comorbid neurological or cognitive disorders (e.g., dementia, delirium, intellectual disability, or history of head trauma)
  • Current substance use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness-Based Yoga
Participants receive a structured mindfulness-based yoga program consisting of 12 sessions over 6 weeks.
Behavioral: Mindfulness-Based Yoga
A structured mindfulness-based yoga program consisting of 12 sessions delivered over 6 weeks. The program includes mindfulness practices, breathing exercises, meditation, and yoga postures conducted in group sessions.
No Intervention: Routine Care
Participants receive routine care without additional intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological Well-Being
Time Frame: Baseline and 6 weeks (post-intervention)
Psychological well-being will be assessed using the Psychological Well-Being Scale (PWB), a validated self-report instrument consisting of 8 items rated on a 7-point Likert scale. Higher scores indicate greater psychological well-being.
Baseline and 6 weeks (post-intervention)
Happiness
Time Frame: Baseline and 6 weeks (post-intervention)
Happiness will be assessed using the Oxford Happiness Questionnaire Short Form (OHQ-SF), a validated self-report scale. Higher scores indicate greater levels of happiness.
Baseline and 6 weeks (post-intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tarsus University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Actual)

August 1, 2024

Study Completion (Actual)

August 1, 2024

Study Registration Dates

First Submitted

March 23, 2026

First Submitted That Met QC Criteria

March 23, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 23, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • MBY-SCZ-RCT-2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on SCHIZOPHRENIA 1 (Disorder)

Clinical Trials on Mindfulness-Based Yoga

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe